Document Detail


Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants.
MedLine Citation:
PMID:  18388503     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Prevalence of obstetric complications in women with deficiency of natural anticoagulants is difficult, because these defects are very rare in general population. Furthermore, the available data on prophylactic intervention in such individuals to decrease the obstetric risk are also very limited. To evaluate in a setting of women with rare hereditary thrombophilias, deficiency of antithrombin, protein C or protein S whether thromboprophylaxis during pregnancy could affect foeto-maternal outcome. Retrospective cohort study in two Italian thrombosis centres: 32 women with an established hereditary deficiency of natural anticoagulants antithrombin, protein C or protein S were enrolled because of a history of unexplained foetal losses with or without venous thromboembolism. Overall, information on the management of 103 pregnancies was obtained and the outcome in the absence or in the presence of enoxaparin treatment was recorded. Live births were recorded in 18 women (56.2%). Ten women had early foetal losses, 16 intrauterine foetal death and six both. Eight pregnancies were treated with enoxaparin. Seven out of eight treated pregnancies [87.5%, 95% confidence interval (CI) 52.9-97.7] and 27 out of 95 not-treated pregnancies (28.4%, 95% CI 20.3-38.1) resulted in the delivery of a live newborn (Fisher exact test: P=0.002), with a risk of foetal loss in untreated pregnancies 3.1 times (95% CI 1.7-3.5) higher than in treated ones. In this setting of patients with rare causes of thrombophilia, antithrombotic prophylaxis during pregnancy improves foeto-maternal outcome.
Authors:
Elvira Grandone; Valerio De Stefano; Elena Rossi; Filomena Cappucci; Donatella Colaizzo; Maurizio Margaglione
Related Documents :
12061293 - Thrombophilia in pregnancy.
7091523 - Management of deep venous thrombosis and pulmonary embolism during pregnancy.
1910183 - A racial and ethnic comparison of family formation and contraceptive practices among lo...
Publication Detail:
Type:  Journal Article; Multicenter Study    
Journal Detail:
Title:  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis     Volume:  19     ISSN:  0957-5235     ISO Abbreviation:  Blood Coagul. Fibrinolysis     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-04-11     Completed Date:  2008-06-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9102551     Medline TA:  Blood Coagul Fibrinolysis     Country:  England    
Other Details:
Languages:  eng     Pagination:  226-30     Citation Subset:  IM    
Affiliation:
Atherosclerosis and Thrombosis Unit, IRCCS, Casa Sollievo della Sofferenza, Poliambulatorio Giovanni Paolo II, Viale Padre Pio, S. Giovanni Rotondo, Foggia, Italy. e.grandone@operapadrepio.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortion, Habitual / etiology,  prevention & control*
Adult
Anticoagulants / therapeutic use*
Cohort Studies
Enoxaparin / therapeutic use*
Female
Humans
Live Birth
Pregnancy
Pregnancy Complications, Hematologic / drug therapy*
Retrospective Studies
Thrombophilia / drug therapy*
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Enoxaparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Whole blood coagulation measured by modified thrombelastography (ROTEM) is impaired in infants with ...
Next Document:  ABO blood group distribution and major cardiovascular risk factors in patients with acute myocardial...